7AZAR D T~ Corneal angiogenie privilege: angiogenic and antiangiog- hie factors in corneal avaseularity, vasculogenesis, and wound heal- ing[ J ]. Trans Am Ophthalmol Soc ,2006, 104:206 - 302.
4Fuchsluger T, Tuerkeli E, Westekemper H, Esser J, Steuhl KP,Meller D. Rate of epithelialisation and re - operations in comeal ulcerstreated with anmiotic membrane transplantation combined with betulinumtoxin-induced ptosis. Gmefes Arch Clin Exp Ophthalmol 2007; 245 (7):955-964.
5Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis : emerging trends andtreatment outcomes. Eye Contact Lens 2006;32(6) :267-271.
7Gris 0,Giiell JL,Lopez - Navidad A,Caballero F, Del Campo Z.Application Of the amniotic membrane in ocular surface pathology. AnnTransplantl999 ;4(3-4) :82-84.
8Shi W,Wang T, Xie L, Li S, Gao H, Liu J,Li H. Risk factors,clinical features,and outcomes of recurrent fungal keratitis after cornealtransplantation. 0phthalmology2010; 117(5) :890-896.
9Mutoh T,Ishikawa I,Matsumoto Y, Chikuda M. A retrospective studyof nine cases of Acanthamoeba keratitis. Clin Ophthalmol 2010 ; 4 :1189-1192.
10Au L, Wechsler D, Spencer F, Fenerty C. Outcome of bleb revisionusing scleral patch graft and coujunctival advancement. J Glaucoma2009;18(4) :331-335.
